Tests:CA 19-9: Difference between revisions
Tests:CA 19-9
m Mark as reviewed |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 73: | Line 73: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Alinity | |Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
Latest revision as of 20:37, 23 September 2026
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | C199 |
| Synonyms | C199
C19-9 19-9 |
| Test Availability | Tested Monday, Wednesday and Friday afternoons.
Please contact the laboratory if testing is required urgently |
| Turnaround Time | 1 – 4 days |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen | Serum |
| Preferred | Yellow-Top SST or Red-Top tube |
| Acceptable | |
| Unacceptable | Plasma |
| Specimen Transportation | |
| Paediatric Requirements | 0.5 mL Red microtainer |
Aliquot Requirements | |
| Sample | Serum |
| Preferred Volume | >500 uL |
| Minimum Volume | 200 uL |
| Aliquot Transportation | Samples should be separated from red cells within 24hrs of collection. |
Clinical Information | |
| Reference Intervals | <37 U/mL |
| Test Method | Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. |
| Advanced Notice | |
| Patient Preparation | |
Comments | |
| Used for monitoring gastrointestinal malignancies
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |
| Owner | Clair Crossley (Crossley1) |
|---|---|
| Last reviewed | 23.09.2026 |
| Next review | 23.09.2027 (OK) |